Heterocyclic compounds having angiotensin II antagonistic activity and use thereof
AssigneeTakeda Chemical Industries, Ltd.
InventorsKeiji Kubo, Yoshiyuki Inada, Takehiko Naka
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Chemical Industries, Ltd.
InventorsKeiji Kubo, Yoshiyuki Inada, Takehiko Naka
Estimating the term…
This invention relates to a compound represented by the formula ##STR1## wherein the ring A stands for a 5-10 membered aromatic heterocyclic group optionally having, besides R.sup.1 and R.sup.2, further substituents; R.sup.1 stands for an optionally substituted hydrocarbon residue which is optionally bonded through a hetero-atom; R.sup.2 stands for a group capable of liberating proton in a living body or a group convertible thereinto; R.sup.3 stands for an 5-7 membered optionally substituted heterocyclic residue having, as a group capable of constituting the ring, carbonyl group, thiocarbonyl group, an optionally oxidized sulfur atom or a group convertible into them; X shows that the ring Y and the ring W are bonded to each other directly or through a spacer having an atomic length of two or less; the ring W and the ring Y are each an optionally substituted aromatic hydrocarbon or aromatic heterocyclic residue; and n denotes an integer of 1 to 3, or a salt thereof and to an angiotensin II antagonistic agent containing the compound (I) or a salt thereof.
A compound represented by the formula:
A compound represented by the formula, ##STR46## wherein the ring A is selected from the class consisting of ##STR47## R.sup.1 may be bonded through a hetero atom and stands for an optionally substituted lower (C.sub.1-6) alkyl;
A compound represented by the formula:
Dependencies are inferred from the claim text.